Ray Dalio Johnson & Johnson Transaction History
Bridgewater Associates, LP
- $23.3 Billion
- Q2 2025
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Johnson & Johnson stock. As of the latest transaction made, Bridgewater Associates, LP holds 2,282,539 shares of JNJ stock, worth $394 Million. This represents 1.5% of its overall portfolio holdings.
Number of Shares
2,282,539
Previous 297,288
667.79%
Holding current value
$394 Million
Previous $49.3 Million
607.19%
% of portfolio
1.5%
Previous 0.24%
Shares
25 transactions
Others Institutions Holding JNJ
# of Institutions
4,637Shares Held
1.76BCall Options Held
18.4MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA237MShares$41 Billion0.61% of portfolio
-
Black Rock Inc. New York, NY198MShares$34.2 Billion0.67% of portfolio
-
State Street Corp Boston, MA133MShares$22.9 Billion0.78% of portfolio
-
Geode Capital Management, LLC Boston, MA60.6MShares$10.5 Billion0.67% of portfolio
-
Jpmorgan Chase & CO New York, NY54.1MShares$9.34 Billion0.7% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $452B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...